2013
DOI: 10.1080/07391102.2012.709459
|View full text |Cite
|
Sign up to set email alerts
|

Micelle-bound conformations of neurohypophyseal hormone analogues modified with a Cα-disubstituted residue: NMR and molecular modelling studies

Abstract: In this study, by applying a combined approach of NMR measurements and molecular modelling, the conformations and the interactions with membrane-like environment of five arginine vasopressin (AVP) or oxytocin (OT) analogues modified with Cα-disubstituted cis-1-amino-4-phenylcyclohexane-1-carboxylic acid in position 2 have been determined. In addition, the AVP analogues were prepared in N-acylated forms with various bulky acyl groups. All of the peptides studied interacted with the mixed dodecylphosphocholine:s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 56 publications
0
4
0
Order By: Relevance
“…20,21 Further NMR studies in micelles (both charged and neutral) will be used and compared with previous literature examining OT in nonpolar solvents (e.g., CDCl 3 , DMSO) 41 and in charged micelles. 59 Several of our OT analogues showed increased potency as compared to OT, demonstrating that our modi cations can improve both pharmacodynamic and pharmacokinetic performance. All of the compounds produced no activity at the AVP1a/1b receptors, suggesting that they may be selective in vivo and avoid side effects caused by AVP activation.…”
Section: Resultsmentioning
confidence: 85%
“…20,21 Further NMR studies in micelles (both charged and neutral) will be used and compared with previous literature examining OT in nonpolar solvents (e.g., CDCl 3 , DMSO) 41 and in charged micelles. 59 Several of our OT analogues showed increased potency as compared to OT, demonstrating that our modi cations can improve both pharmacodynamic and pharmacokinetic performance. All of the compounds produced no activity at the AVP1a/1b receptors, suggesting that they may be selective in vivo and avoid side effects caused by AVP activation.…”
Section: Resultsmentioning
confidence: 85%
“…22,23 Further NMR studies in micelles (both ionic and neutral) will be used and compared with previous literature examining OT in nonpolar solvents (e.g., CDCl 3 , DMSO) 60,61 and in ionic (e.g., SDS) micelles. 62 Several analogues showed increased potency compared to OT, demonstrating that relatively minor modifications can enhance both pharmacodynamic and pharmacokinetic performance. All compounds described here show no activity at the AVP1a/1b receptors, implying that they will be selective in vivo and avoid side effects caused by AVP activation.…”
Section: Acs Medicinalmentioning
confidence: 99%
“…Conformational data of OT in aqueous solution has been published, and the receptor-bound conformation of OT•OTR was recently determined via cryo-EM . The crystal structure of OT bound to OTR has been recently determined via cryo-EM. , Further NMR studies in micelles (both ionic and neutral) will be used and compared with previous literature examining OT in nonpolar solvents (e.g., CDCl 3 , DMSO) , and in ionic (e.g., SDS) micelles …”
mentioning
confidence: 99%
“…OT hormone has been known to be of the topic of immense investigation in lieu of its biological functions such as the maintenance of labor and milk ejection in mammals (Gimpl & Fahrenholz, 2001), facilitating the sexual maturation (Parent et al, 2008), stimulating the pre-ovulatory luteinizing hormone surge (Rettori, Canteros, Renoso, Gimeno, & McCann, 1997), and also its biomedical application such as in the treatment of autism (Newschaffer et al, 2007). Toward understanding the biological activities of OT, various works have been reported to be carried out for studying the interactions of OT with neurophysin (Blumenstein, Hruby, Viswanatha, & Chaturvedi, 1984;Eubanks, Lu, Peyton, & Breslow, 1999;Live, Cowburn, & Breslow, 1987;Rose, Wu, Hsiao, Breslow, & Wang, 1996) and with receptor (Bélec, Blankenship, & Lubell, 2005;Budesínsky, Procházka, & Slaninová, 2005;Carnazzi et al, 2001;Lebl et al, 1990;Lubecka, Sikorska, Marcinkowska, & Ciarkowski, 2014;Sikorska & Kwiatkowska, 2013;Turner, Matsoukas, & Moore, 1990).…”
Section: Introductionmentioning
confidence: 99%